Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 104Stomach Neoplasms 19Inflammatory Breast Neoplasms 12Esophageal Neoplasms 11Triple Negative Breast Neoplasms 6Sarcoma 6Carcinoma, Hepatocellular 5Lymphoma, Large B-Cell, Diffuse 4Liver Neoplasms 4Adenocarcinoma Of Esophagus 4Primary Breast Cancer 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Hemangiosarcoma 3Unspecified Adult Solid Tumor, Protocol Specific 2Testicular Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasm Metastasis 2Malignant mesenchymal tumor 2Lymphoma, B-Cell, Marginal Zone 2Liposarcoma 2Hemangiopericytoma, Malignant 2Gallbladder Neoplasms 2Fibrosarcoma 2Desmoplastic Small Round Cell Tumor 2Chondrosarcoma 2Carcinoma, Ductal, Breast 2Breast Neoplasms, Male 2

Interventions

pegfilgrastim 26Filgrastim 24Cyclophosphamide 8Docetaxel 7Etoposide 6pegylated granulocyte colony-stimulating factor 5Cytarabine 5eflapegrastim 4Granulocyte Colony-Stimulating Factor 4Leucovorin 3Fluorouracil 3Doxorubicin 3Cyclosporine 3Cefepime 3Caspofungin 3Carboplatin 3liposomal amphotericin B 2Vincristine 2Vancomycin 2Topotecan 2Methylprednisolone 2Methotrexate 2Itraconazole 2Irinotecan 2Ifosfamide 2Idarubicin 2Fluconazole 2Daunorubicin 2Cisplatin 2Amikacin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neutropenia × Epirubicin × Clear all
NCT00002866 2020-04-01

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Canadian Cancer Trials Group

Phase 1 Completed
50 enrolled
Breast

Breast Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡